Dihydromyricetin Ameliorates Cardiac Ischemia/Reperfusion Injury through Sirt3 Activation

Figure 1

DHM alleviated MI/R injury. (a, b) Lactate dehydrogenase (LDH) and creatine kinase-MB (CK-MB). (c) The infarct area in each group. (d, e) Quantitative analysis of infarct area and AAR/LV. Mean ± SEM (n=12), P<0.05 vs WT+sham group; ^#P<0.05 vs Sirt3^−/− + sham group; ^§P < 0.05 vs MI/R group; P<0.05 vs Sirt3^−/−+MI/R group; ^&P<0.05 vs MI/R +DHM group.

(a)

(b)

(c)

(d)

(e)